Sirolimus-induced leukocytoclastic vasculitis: the second case reported.
Alessandro C
AC
Pasqualotto
Patrcia D
PD
Bianco
Teresa C T
TC
Sukiennik
Roque
R
Furian
Valter D
VD
Garcia
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009336:Necrosis; D020123:Sirolimus / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced* / Q000473:pathology
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D020123:Sirolimus